Opinion

Video

Mihir Shah, MD, on the need for mental health screening in patients with prostate cancer

Key Takeaways

  • Prostate cancer patients have a higher depression incidence (10%-40%) than the general population (9%).
  • Racial disparities exist in depression diagnosis and treatment among prostate cancer patients on androgen deprivation therapy.
SHOW MORE

“We need to close that gap, and just as a general rule, screen our prostate cancer patients more closely for depression, especially those with androgen deprivation therapy,” says Mihir S. Shah, MD.

In this video, Mihir S. Shah, MD, shares key take-home messages from the study, “Racial Disparities in Diagnosis and Treatment of Depression Associated with Androgen Deprivation Therapy for Prostate Cancer,” for which he served as the senior author. Shah is a clinical assistant professor and vice chair of clinical research at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, Pennsylvania.

Video Transcript:

I think what we have learned in literature is that the incidence of depression in patients with prostate cancer is about 10% to 40% which is higher than the similar incidence in the general population, which is about 9%. So, our patients with prostate cancer at a higher risk of depression. Therefore we need to screen them better. This study also suggests that there might be a difference along racial lines when it comes to incidence and treatment, especially [for] our patients that are being treated with androgen deprivation therapy. We need to close that gap, and just as a general rule, screen our prostate cancer patients more closely for depression, especially those with androgen deprivation therapy.

This transcription has been edited for clarity.

Related Videos
Ellen Cahill, MD, answers a question during a video interview
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Raevti Bole, MD, answers a question during a video interview
Oliver Sartor, MD, is featured in this series.
Justin Dubin, MD, answers a question during a video interview
Landon Trost, MD, answers a question during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.